The Prognosis of Pulmonary Metastasectomy Depends on the Location of the Primary Colorectal Cancer

被引:51
|
作者
Cho, Jong Ho [1 ]
Hamaji, Masatsugu [1 ]
Allen, Mark S. [1 ]
Cassivi, Stephen D. [1 ]
Nichols, Francis C., III [1 ]
Wigle, Dennis A. [1 ]
Shen, K. Robert [1 ]
Deschamps, Claude [1 ]
机构
[1] Mayo Clin, Div Gen Thorac Surg, Rochester, MN 55905 USA
来源
ANNALS OF THORACIC SURGERY | 2014年 / 98卷 / 04期
关键词
LUNG METASTASES; PULMICC-TRIAL; COLON-CANCER; CARCINOMA; SURVIVAL; MANAGEMENT; RECURRENCE; RESECTION;
D O I
10.1016/j.athoracsur.2014.05.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Rectal cancer has a higher risk of developing lung metastasis compared with colon cancer. It is unclear whether the prognosis after pulmonary metastasectomy for these distinct tumors is different. Methods. Patients who underwent pulmonary metastasectomy for colorectal carcinoma were analyzed for survival and patterns of recurrence depending on the location of the primary colorectal cancer. Multivariate regression analysis was performed to identify clinical variables predictive of survival after pulmonary metastasectomy. Results. Between 1985 and 2012, 698 patients underwent pulmonary metastasectomy for metastatic colorectal cancer. Complete information was available in 626 patients. These patients were divided into groups based on whether the primary tumor was colon or rectal in origin. Median follow-up was 45.5 months (range, 23 to 287 months). There were no statistical differences between the two groups in terms of number of lung metastases, tumor size, or lymph node involvement. There was no difference in overall survival (p = 0.545). Five-year disease-free survival for colon cancer patients was 67.2% compared with 60.1% for rectal cancer (p = 0.004). The most common sites of recurrence after pulmonary metastasectomy were liver in colon cancer and lung in rectal cancer. Multivariate Cox proportional hazards analysis indicated that rectal cancer (hazard ratio, 1.39; 95% confidence interval, 1.07 to 1.83; p = 0.015) and multiple metastases (>3; hazard ratio, 1.41; 95% confidence interval, 1.04 to 1.89; p = 0.027) were independent adverse risk factors affecting disease-free survival after pulmonary metastasectomy. Conclusions. Disease-free survival and site of recurrence after pulmonary metastasectomy for colorectal carcinoma are dependent on the site of the primary tumor. Lung metastases from rectal cancer have a worse disease-free survival compared with colon cancer. This may influence treatment and follow-up strategies. (C) 2014 by The Society of Thoracic Surgeons
引用
收藏
页码:1231 / 1237
页数:7
相关论文
共 50 条
  • [31] History and present status of pulmonary metastasectomy in colorectal cancer
    Tom Treasure
    Miel Miloevi
    Francesca Fiorentino
    Joachim Pfannschmidt
    World Journal of Gastroenterology, 2014, 20 (40) : 14517 - 14526
  • [32] History and present status of pulmonary metastasectomy in colorectal cancer
    Treasure, Tom
    Milosevic, Misel
    Fiorentino, Francesca
    Pfannschmidt, Joachim
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (40) : 14517 - 14526
  • [33] Pulmonary metastasectomy in colorectal cancer: a randomized controlled trial
    Macbeth, Fergus
    Williams, Norman R.
    Treasure, Tom
    ANZ JOURNAL OF SURGERY, 2021, 91 (03) : 473 - 473
  • [34] Pulmonary metastasectomy in colorectal cancer: PulMiCC and future trials
    Williams, Norman R.
    Macbeth, Fergus
    Treasure, Tom
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2020, 10 (11) : 2215 - 2217
  • [35] Prognostic factors in the pulmonary metastasectomy from colorectal cancer
    Fukada, Masahiro
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yamamoto, Hirotaka
    Shirahashi, Koyo
    Iwata, Hisashi
    Doi, Kiyoshi
    Yoshida, Kazuhiro
    CANCER SCIENCE, 2021, 112 : 792 - 792
  • [36] Pulmonary Metastasectomy in Colorectal Cancer: thePulMiCCrandomised controlled trial
    Treasure, Tom
    Leonard, Pauline
    Milosevic, Misel
    Williams, Norman R.
    Macbeth, Fergus
    Farewell, Vern
    BRITISH JOURNAL OF SURGERY, 2020, 107 (11) : E489 - E490
  • [37] Staged pulmonary and hepatic metastasectomy in colorectal cancer - is it worth it?
    Reddy, RHV
    Kumar, B
    Shah, R
    Mirsadraee, S
    Papagiannopoulos, K
    Lodge, P
    Thorpe, JAC
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (02) : 151 - 154
  • [38] Pulmonary metastasectomy in colorectal carcinoma
    Beckers, Paul
    Berzenji, Lawek
    Yogeswaran, Suresh K.
    Lauwers, Patrick
    Bilotta, Giada
    Shkarpa, Nikol
    Hendriks, Jeroen
    Van Schil, Paul E.
    JOURNAL OF THORACIC DISEASE, 2021, 13 (04) : 2628 - 2635
  • [39] Commentary: Molecular biology, location, and survival following pulmonary metastasectomy for colorectal carcinoma
    McGuire, Anna L.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (01): : 307 - 308
  • [40] Pulmonary metastasectomy and repeat metastasectomy for colorectal pulmonary metastases: outcomes from the Dutch Lung Cancer Audit for Surgery
    van Dorp, Martijn
    Wolfhagen, Nienke
    Torensma, Bart
    Dickhoff, Chris
    Kazemier, Geert
    Heineman, David J.
    Schreurs, Wilhelmina H.
    BJS OPEN, 2023, 7 (03):